We found that knockdown of CD133 rarely suppressed the in vitro proliferation of both cancer cells, while knockdown of CD133 significantly decreased the invasive potentials of both cancer cells (p<0.05) (Figure 8B). The gene discussed is PROM1; the disease is cancer.